- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 354 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 341 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 04.12.25 | Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview | 1 | GlobeNewswire (USA) | ||
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 401 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 275 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 428 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 516 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 365 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 407 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09.25 | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 401 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen | |
| 10.09.25 | Exousia Pro, Inc.: Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets | 335 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic... ► Artikel lesen | |
| 08.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division | 453 | ACCESS Newswire | Exousia Health is expected to have an initial patient base of 1,000 active clients, projected to generate approximately $50,000 in monthly revenue. ORLANDO, FL / ACCESS Newswire / September 8, 2025... ► Artikel lesen | |
| 03.09.25 | Exousia Pro, Inc.: Exousia Pro Creates New Subdivisions | 454 | ACCESS Newswire | Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion... ► Artikel lesen | |
| 25.06.25 | Marijuana Inc.: Exousia Pro Files Reg A. | 290 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / June 25, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of... ► Artikel lesen | |
| 18.06.25 | Marijuana Inc.: Exousia Pro Expands its Scientific Advisory Board | 624 | ACCESS Newswire | Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board. ORLANDO, FLORIDA / ACCESS Newswire / June 18, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company... ► Artikel lesen | |
| 30.04.25 | Marijuana Inc.: Exousia Pro Will Launch a Web Series with Our New Consultant | 327 | ACCESS Newswire | Dr. Marvin Hausman is joining Exousia Pro as a Consultant and will host a weekly series. ORLANDO, FL / ACCESS Newswire / April 30, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage... ► Artikel lesen | |
| 29.04.25 | Marijuana Inc.: Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application | 356 | ACCESS Newswire | - Rigorous humanized mouse model enhances credibility and translatability of results- Key preclinical data to support FDA Orphan Drug Application- In vitro success signals potential for exosome-based... ► Artikel lesen | |
| 21.04.25 | Marijuana Inc.: Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview | 422 | ACCESS Newswire | A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc.,... ► Artikel lesen | |
| 17.04.25 | Marijuana Inc.: Exousia Pro Offers Guidance on New Subdivisions | 414 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is... ► Artikel lesen | |
| 08.04.25 | Marijuana Inc.: Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show | 449 | ACCESS Newswire | Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 241,80 | 0,00 % | JEFFERIES stuft Sartorius Vorzuege auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Sartorius mit einem Kursziel von 275 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Laborausrüster zu den... ► Artikel lesen | |
| SERVE ROBOTICS | 9,200 | 0,00 % | Serve Robotics Partners With Uber To Expand Services To Fort Lauderdale | WASHINGTON (dpa-AFX) - Serve Robotics Inc. (SERV), a sidewalk delivery company, Friday announced that it is partnering with Uber Technologies, Inc. (UBER), the mobility technology major, to... ► Artikel lesen | |
| GPGI | 23,050 | +4,16 % | GPGI, Inc. - 8-K, Current Report | ||
| PVA TEPLA | 19,840 | 0,00 % | DAX-Check LIVE: Henkel, Infineon, PVA TePla, SAP, SMA Solar, Zalando im Fokus | Während sich die Edelmetallmärkte beruhigt haben, kehrte gestern an den Aktienmärkten neue Unruhe zurück. Der DAX verlor nach einem starken Start an Schwung und rutschte ins Minus. Zum Handelsbeginn... ► Artikel lesen | |
| GEOSPACE TECHNOLOGIES | 9,370 | -41,44 % | GEOSPACE TECHNOLOGIES CORP - 8-K, Current Report | ||
| EVOLV TECHNOLOGIES | 5,285 | 0,00 % | Why Analysts Favor Evolv Technologies (EVLV) | ||
| DRONESHIELD | 1,688 | -6,01 % | DroneShield enttäuscht! Plug Power kämpft ums Überleben! American Atomics Aktie vor einer überfälligen Rally?! | Tech-Analyst Pip Klöckner zeichnet für 2026 ein klares Bild: Er erwartet, dass Nvidia-CEO Jensen Huang im laufenden Jahr zum größten Energie-Lobbyisten aufsteigt. Ohne zusätzliche, verlässliche Energie... ► Artikel lesen | |
| UNUSUAL MACHINES | 11,120 | 0,00 % | Unusual Machines, Inc.: Unusual Machines Promotes Drew Camden to President | Expanded role reflects operational scale and execution across U.S. manufacturing ORLANDO, FLORIDA / ACCESS Newswire / February 2, 2026 / Unusual Machines today announced the promotion of Drew Camden... ► Artikel lesen | |
| 2G ENERGY | 34,000 | 0,00 % | ALARM bei Plug Power! 2G Energy und der KI-BOOM! 100 % KURSPOTENZIAL bei der A.H.T. Syngas Aktie! | Über 100 % Kurspotenzial sehen Analysten bei der Aktie von A.H.T. Syngas. Aus Sicht der Experten steht das Unternehmen vor einem Wachstumsschub. Das Marktpotenzial für synthetischen Erdgasersatz aus... ► Artikel lesen | |
| INNOVATIVE SOLUTIONS & SUPPORT | 18,020 | 0,00 % | IS&S Rebrands to Innovative Aerosystems | New brand identity reflects focus on integrating advanced avionics with intelligent system designs to deliver innovative aerospace solutions
EXTON, Pa.--(BUSINESS WIRE)--Innovative Solutions & Support... ► Artikel lesen | |
| PFEIFFER VACUUM TECHNOLOGY | 164,40 | 0,00 % | EQS-PVR: Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Pfeiffer Vacuum Technology AG
Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading... ► Artikel lesen | |
| CODA OCTOPUS | 10,690 | -5,90 % | Coda Octopus Group, Inc.: Coda Octopus Group Reports Fiscal 2025 Financial Results | ORLANDO, FL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. ("CODA" or the "Company") (Nasdaq: CODA) a global market leader in real-time 4D/5D/6D imaging sonar technology and AI-enabled... ► Artikel lesen | |
| ENVIROTAINER AG | 27,200 | 0,00 % | Dividendenbekanntmachungen (01.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AURIZON HOLDINGS LIMITED AU000000AZJ1 0,065 AUD 0,0363 EUR BITCOIN GROUP SE DE000A1TNV91 - 0,1 EUR CHINA MOBILE LTD HK0941009539 2... ► Artikel lesen | |
| RAIL VISION | 4,190 | 0,00 % | Rail Vision Ltd.: Rail Vision: Quantum Transportation Unveils Transformer Neural Decoder That Outperforms Classical QEC Algorithms in Simulations | ||
| RCM TECHNOLOGIES | 20,050 | -0,69 % | RCM Technologies, Inc. Announces Third Quarter Results | PENNSAUKEN, N.J., Nov. 05, 2025 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through... ► Artikel lesen |
Das Unternehmen EXOUSIA ADVANCED MATERIALS INC kann der Branche Sonstige Technologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.